Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Weiss

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Frontiers in Neuroscience|September 12, 2019
Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive ImmunoassayCristina Cariulo, Paola Martufi, Margherita Verani, et al.
ACS Pharmacology & Translational Science|February 22, 2021
Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance MechanismsVerena Apfel, Damien Begue, Valentina Cordo', et al.
Plos One|May 23, 2012
High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brainMartin C Herzig, Michael Bidinosti, Tatjana Schweizer, et al.
The Journal of Clinical Investigation|September 22, 2012
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progressionAndreas Weiss, Ulrike Träger, Edward J Wild, et al.
Human Molecular Genetics|June 19, 2018
Identification of distinct conformations associated with monomers and fibril assemblies of mutant huntingtinJan Ko, J Mario Isas, Adam Sabbaugh, et al.
Neuron|June 26, 2012
Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesisHolly B Kordasiewicz, Lisa M Stanek, Edward V Wancewicz, et al.
Analytical Biochemistry|August 12, 2009
Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's diseaseAndreas Weiss, Dorothée Abramowski, Miriam Bibel, et al.
Plos One|December 3, 2014
Polyglutamine- and temperature-dependent conformational rigidity in mutant huntingtin revealed by immunoassays and circular dichroism spectroscopyValentina Fodale, Natalie C Kegulian, Margherita Verani, et al.
Plos One|September 18, 2012
Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon agingDavid Marcellin, Dorothee Abramowski, Douglas Young, et al.
Plos One|November 9, 2013
Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumorsSimon Wöhrle, Andreas Weiss, Moriko Ito, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Frontiers in Neuroscience|September 12, 2019
Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive ImmunoassayCristina Cariulo, Paola Martufi, Margherita Verani, et al.
ACS Pharmacology & Translational Science|February 22, 2021
Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance MechanismsVerena Apfel, Damien Begue, Valentina Cordo', et al.
Plos One|May 23, 2012
High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brainMartin C Herzig, Michael Bidinosti, Tatjana Schweizer, et al.
The Journal of Clinical Investigation|September 22, 2012
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progressionAndreas Weiss, Ulrike Träger, Edward J Wild, et al.
Human Molecular Genetics|June 19, 2018
Identification of distinct conformations associated with monomers and fibril assemblies of mutant huntingtinJan Ko, J Mario Isas, Adam Sabbaugh, et al.
Neuron|June 26, 2012
Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesisHolly B Kordasiewicz, Lisa M Stanek, Edward V Wancewicz, et al.
Analytical Biochemistry|August 12, 2009
Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's diseaseAndreas Weiss, Dorothée Abramowski, Miriam Bibel, et al.
Plos One|December 3, 2014
Polyglutamine- and temperature-dependent conformational rigidity in mutant huntingtin revealed by immunoassays and circular dichroism spectroscopyValentina Fodale, Natalie C Kegulian, Margherita Verani, et al.
Plos One|September 18, 2012
Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon agingDavid Marcellin, Dorothee Abramowski, Douglas Young, et al.
Plos One|November 9, 2013
Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumorsSimon Wöhrle, Andreas Weiss, Moriko Ito, et al.
Pageof 11